国药现代：公司重视投资者权益保护

Core Viewpoint - The company emphasizes the protection of investor rights and has established a series of measures to enhance shareholder returns and stabilize investor expectations [1] Group 1 - The company has developed a "Market Value Management System" and a "Shareholder Return Plan" for the next three years (2025-2027) [1] - Since 2024, the company has steadily increased its cash dividend ratio [1] - The company is committed to the principle of "investor-centric" management to promote stable business development [1]